Skip Navigation


Rheumatology Advance Access originally published online on May 5, 2006
Rheumatology 2006 45(6):783-784; doi:10.1093/rheumatology/kel134
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
45/6/783    most recent
kel134v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bruchfeld, A.
Right arrow Articles by Cacoub, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bruchfeld, A.
Right arrow Articles by Cacoub, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTER TO THE EDITOR

Treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia—anti-viral therapy vs rituximab

Annette Bruchfeld1,2, David Saadoun3 and Patrice Cacoub3

1 The Feinstein Institute for Medical Research, North Shore-LIJHS, 350 Community Drive, Manhasset, NY 11030, USA, 2 Division of Renal Medicine, Karolinska University Hospital/Huddinge, Karolinska Institutet, S-141 86 Stockholm, Sweden and 3 Department of Internal Medicine and CNRS UMR 7087, Hôpital La Pitié-Salpêtrière, 83, Boulevard de l’Hôpital, 75651 Cedex 13 Paris, France

Correspondence to: A. Bruchfeld. E-mail: Amette.Bruchfeld@ki.se

The first 10% of the full text of this article appears below.

SIR, Quartuccio et al. [1] reported a case series of five patients with HCV-associated mixed cryoglobulinaemic vasculitis. Two of the patients had previously received pegylated interferon, but none had been treated with ribavirin. Another two patients were reported to have milder chronic hepatitis upon liver biopsy and were infected with genotype 2a/2c, both . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?